In cases in which STIC is observed, the incidence of peritoneal cancer is significantly higher; therefore, we feel it is appropriate to monitor patient progression using transvaginal ultrasound and cancer antigen 125 (CA125), similar to ovarian cancer. This evidence concerns the gene MUC16 and peritoneum cancer.